MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

Medtronic on Tuesday priced a planned initial public offering for its MiniMed diabetes spinoff at up to $784 million. MiniMed ...

Medtronic’s (MDT) diabetes care subsidiary, MiniMed Group, has officially kicked off its IPO roadshow in a bid to list as an ...

March 5 (Reuters) - MiniMed, the diabetes business of medical device maker Medtronic, said on Thursday it has raised $560 ...

Shares of MiniMed Group Inc., a diabetes management firm that will be separated from health-care giant Medtronic Plc, slid 8% in its trading debut, after the firm raised $560 million in an initial ...

Medtronic (NYSE:MDT) has launched its MiniMed Go Smart MDI system with the Simplera sensor in Europe. The system connects the ...

As of the closing of the IPO, Medtronic plc (Medtronic) owns approximately 90.03% of MiniMed common stock. Medtronic has previously stated that its preferred path to complete the ...

MiniMed has operated as Medtronic's diabetes business unit for nearly 25 years. Founded in 1983, it mainly produces automated insulin pumps, continuous glucose monitors and smart ...

MiniMed has launched a roadshow for its initial public offering. The IPO is part of Medtronic's plan to separate its diabetes business into an independent company. MiniMed will offer 28 million shares ...

Medtronic's diabetes unit MiniMed raises $560 million in a U.S. IPO but debuts on the Nasdaq below its offer price. CVS ...

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.